President Donald Trump said in an interview that aired Sunday that he did not plan to extend the July 9 tariff deadline he ...

Novartis’ ground breaking cancer T-cell therapy CTL019 has won unanimous backing from advisers to the FDA, paving the way for approval in the coming months.